Literature DB >> 12502491

Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia.

Pankaj Shah1, Adrian Vella, Ananda Basu, Rita Basu, Aron Adkins, W Frederick Schwenk, C Michael Johnson, K Sreekumaran Nair, Michael D Jensen, Robert A Rizza.   

Abstract

The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at approximately 8.3 mmol/l and insulin was increased to approximately 300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 +/- 2.6 vs. 65.0 +/- 7.9 micro mol. kg(-1). min(-1)). Whole-body glucose disappearance (37.0 +/- 2.2 vs. 70.9 +/- 8.7 micro mol. kg(-1). min(-1); P < 0.001) and leg glucose uptake (24.3 +/- 4.2 vs. 59.6 +/- 10.0 micro mol. kg fat-free mass of the leg(-1). min(-1); P < 0.02) were also lower, whereas splanchnic glucose production (8.2 +/- 0.8 vs. 4.3 +/- 0.7 micro mol. kg(-1). min(-1); P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole- body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502491     DOI: 10.2337/diabetes.52.1.38

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  Metabolic actions of insulin in men and women.

Authors:  Faidon Magkos; Xuewen Wang; Bettina Mittendorfer
Journal:  Nutrition       Date:  2010-04-14       Impact factor: 4.008

Review 2.  Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.

Authors:  Yolanda F Otero; John M Stafford; Owen P McGuinness
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

3.  Different effects of hyperlipidic diets in human lactation and adulthood: growth versus the development of obesity.

Authors:  Marià Alemany
Journal:  Reprod Biol Endocrinol       Date:  2011-07-28       Impact factor: 5.211

4.  What is type 2 diabetes?

Authors:  Galina Smushkin; Adrian Vella
Journal:  Medicine (Abingdon)       Date:  2010-11-01

5.  Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA.

Authors:  J A Bell; E Volpi; S Fujita; J G Cadenas; B B Rasmussen
Journal:  Diabetologia       Date:  2006-07-26       Impact factor: 10.122

6.  Errors in measuring plasma free fatty acid concentrations with a popular enzymatic colorimetric kit.

Authors:  Yilin Song; Lianzhen Zhou; Michael D Jensen
Journal:  Clin Biochem       Date:  2019-01-29       Impact factor: 3.281

7.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

8.  Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes.

Authors:  Kazuma Ogiso; Nobuyuki Koriyama; Takahiko Obo; Akinori Tokito; Yoshihiko Nishio
Journal:  Diabetol Int       Date:  2020-08-03

9.  Influence of Oreocnide integrifolia (Gaud.) Miq on IRS-1, Akt and Glut-4 in Fat-Fed C57BL/6J Type 2 Diabetes Mouse Model.

Authors:  Selvaraj Jayaraman; Anandwardhan A Hardikar; A V Ramachandran
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-13       Impact factor: 2.629

10.  Free fatty acids, cardiovascular disease, and mortality in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Sarah O Nomura; Amy B Karger; Natalie L Weir; Daniel A Duprez; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2020-06-10       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.